Isofol Medical AB (publ) (STO:ISOFOL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.8440
-0.0120 (-1.40%)
Aug 29, 2025, 5:29 PM CET

Isofol Medical AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
--0.7212.822.4137.12
Upgrade
--0.7212.822.4137.12
Upgrade
Revenue Growth (YoY)
---94.37%-42.89%-39.63%-
Upgrade
Cost of Revenue
41.2938.7335.14143.71196.71199.54
Upgrade
Gross Profit
-41.29-38.73-34.42-130.92-174.31-162.42
Upgrade
Selling, General & Admin
12.558.487.4234.7527.7222.74
Upgrade
Other Operating Expenses
-0.01-0.01-0.191.810.84-0.43
Upgrade
Operating Expenses
12.548.487.2736.6330.1624.08
Upgrade
Operating Income
-53.83-47.21-41.68-167.54-204.47-186.5
Upgrade
Interest Expense
-0--0.01--0.17-0.15
Upgrade
Interest & Investment Income
2.193.724.570.150.010
Upgrade
Currency Exchange Gain (Loss)
-0.65-0.053.790.84-0.33
Upgrade
Other Non Operating Income (Expenses)
---3.813.53-2.01
Upgrade
EBT Excluding Unusual Items
-52.29-43.49-37.07-159.79-200.25-188.99
Upgrade
Pretax Income
-52.29-43.49-37.07-159.79-200.25-188.99
Upgrade
Income Tax Expense
-----0
Upgrade
Net Income
-52.29-43.49-37.07-159.79-200.25-188.99
Upgrade
Net Income to Common
-52.29-43.49-37.07-159.79-200.25-188.99
Upgrade
Shares Outstanding (Basic)
15916216216212661
Upgrade
Shares Outstanding (Diluted)
15916216216212661
Upgrade
Shares Change (YoY)
-3.53%--28.55%104.40%91.76%
Upgrade
EPS (Basic)
-0.33-0.27-0.23-0.99-1.59-3.07
Upgrade
EPS (Diluted)
-0.33-0.27-0.23-0.99-1.59-3.07
Upgrade
Free Cash Flow
-52.77-41.99-52.54-192.68-188.43-160.27
Upgrade
Free Cash Flow Per Share
-0.33-0.26-0.33-1.19-1.50-2.61
Upgrade
Operating Margin
---5781.41%-1309.24%-912.50%-502.43%
Upgrade
Profit Margin
---5141.61%-1248.68%-893.70%-509.15%
Upgrade
Free Cash Flow Margin
---7286.55%-1505.66%-840.94%-431.77%
Upgrade
EBITDA
-53.83-47.21-41.65-167.48-204.39-186.3
Upgrade
D&A For EBITDA
000.040.070.080.2
Upgrade
EBIT
-53.83-47.21-41.68-167.54-204.47-186.5
Upgrade
Revenue as Reported
--0.7212.822.4137.14
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.